Samsung Sdi Co., Inc.

Lg Electronics Inc.

Seoul National University

Snu Rdb Foundation

Ajou University Industry-academic Cooperation Foundation

Bioleaders Corporation

Korea Institute of Science and Technology

Osong Medical Innovation Foundation, Korea University Research and Business Foundation

Lg Hausys, Ltd.

Korea Research Institute of Bioscience and Biotechnology

Sfc Co., Ltd.

Daewoong Pharmaceutical Co., Ltd.

Gachon University of Industry-academic Cooperation Foundation

Chong Kun Dang Pharmaceutical Corporation

The Industry & Academic Cooperation in Chungnam National University

Ji Yeon Kim

Ja Young Hwang

Kyoung Ku Kang

Kyoung Soo Park

Kwang Jin Jung

Young Ju Shin

Sung Sup Park

Young Woo Park

Byeong Geun Son

Il Jin Kim

Do Young Kim

Sung Hyun Mun

Dong Myeong Shin

Jae Sun Han

Kyoung Hun Shin

Haryoung Poo

Chul Joong Kim

Won Hee Suh

Eun Sun Kim

Ji Young Lee

Hee Jin Kim

Jin Young Lee

Ji Ho Kim

Ha Na Kim

Gwang Hwan Lee

Moon-Hee Sung

Songyi Baek

Kwang Soo Kim

Kyungjin Moon

Seung-Pyo Hong

Byeong Soo Kim

Yoon Seok Yang

Bong-Rae Cho

Min Hyo Ki

Hoon Jai Chun

Soon Young Kwon

Gun Young Heo

Jong Hun Lee

Kyoung Gon Park

So Hyun Park

Jeong Hwan Hwang

Il Han Lee

Ji Young Han

Woo Jung Shin

Dong-Hyeon Kim

Jung Hwan Park

Moon Hee Sung

Chul-June Choi

Se Mi Heo

Hyun Joo Seo

Jee Hyun Park

Youn Jo Ko

Jin Young Ko

Sung Won An

Chang Su Lim

Dae San Kang

Bo Hoon Kim

Long Chun Xu

Young Suk Kim

Chang Yuil Kang

Yoon Ok Nam

Won Jun Lee

Ji Na Choi

Dong Eun Kang

Woo Sung Chang

An adhesive film, a scattering prevention film including the same, and an optical display apparatus including the same are provided. An adhesive film is formed of an adhesive composition including: a polymerization product including a hydroxyl group-containing (meth)acrylic copolymer; and an alkylene oxide cross-linking agent. The adhesive film contains a substituted monocyclic cyclyloxy group and has a peel strength of about 950 gf/in or more, as measured with respect to a glass plate at about 25° C.

Adhesive film, scattering prevention film comprising the same and optical display apparatus comprising the same

Provided are an adhesive film, an optical member comprising same, and an optical display device comprising same, the adhesive film being formed of a composition comprising a hydroxyl group-containing (meth)acrylic copolymer and particles having a refractive index of about 1.5 or greater, wherein the adhesive film has a refractive index of about 1.5 or greater, and the adhesive film satisfies expression 1 and expression 2.

Adhesive film, optical member comprising same, and optical display device comprising same

The present invention provides a pharmaceutical composition of a single dosage form for treating hypertension and hyperlipidemia. According to the present invention, compartments comprising a drug are formulated in separate forms so as to solve problems related to the dissolution and absorption of the drug due to drug interaction, and a biologically equivalent preparation can be obtained when compared to conventional single preparation.

Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia

Disclosed are an apparatus and control method for recommending an application based on a recognized situation of a user of an electronic device by executing an artificial intelligence (AI) algorithm and/or machine learning algorithm in a 5G environment connected for the Internet of Things and a driving method thereof. The apparatus control method according to an embodiment of the present disclosure includes applying context information including at least one of environmental information collected through a sensor of the electronic device or a network, or usage information generated by the use of the electronic device to a machine learning based first learning model in response to a user input, and displaying, on a display, a first shortcut related to an application determined on the basis of a result of applying the context information to the first learning model and displaying, on the display, a second shortcut related to a preset application.

Apparatus and control method for recommending applications based on context-awareness

Provided are a method of preparing retinal ganglion cells by differentiation of stem into retinal ganglion cells, retinal ganglion cells differentiated by the method, a method of screening for a death inhibitor or a proliferation promoter of retinal ganglion cells using the retinal ganglion cells differentiated by the method, a kit of screening for the death inhibitor or the proliferation promoter of retinal ganglion cells including the retinal ganglion cells differentiated by the method, a pharmaceutical composition for treating glaucoma or optic neuropathy including the retinal ganglion cells, a method of treating glaucoma or optic neuropathy including the step of administering the retinal ganglion cells to a subject suspected of having glaucoma or optic neuropathy, and a method of preparing a mature retinal ganglion cell line.

Method for differentiation into retinal ganglion cells from stem cells

Discloses is a method of manufacturing a micro-needle. The method includes a step of preparing a medicinal solution, a step of forming a plurality of tips with the medicinal solution, and a step of forming a cavity in each of the tips. In accordance with such a configuration, a micro-needle in which cavities are formed is provided, whereby it is possible to administer a fixed amount of medicine in a short time.

Micro-needles and method of manufacturing the same

An anisotropic conductive film composition, an anisotropic conductive film prepared using the same, and a connection structure using the same, the anisotropic conductive film including a binder resin; a curable alicyclic epoxy compound; a curable oxetane compound; a quaternary ammonium catalyst; and conductive particles, wherein the anisotropic conductive film has a heat quantity variation rate of about 15% or less, as measured by differential scanning calorimetry (DSC) and calculated by Equation 1:Heat quantity variation rate (%)=[()/]&#xd7;100&#x2003;&#x2003;Equation 1

Composition for anisotropic conductive film, anisotropic conductive film, and connection structure using the same

A semiconductor device connected by an anisotropic conductive film, the anisotropic conductive film having a differential scanning calorimeter onset temperature of 60&#xb0; C. to 85&#xb0; C., and a elastic modulus change of 30% or less, as calculated by Equation 1, below,Elastic modulus change(%)={()/}&#xd7;100&#x2003;&#x2003;[Equation 1] wherein Mis an initial elastic modulus in kgf/cmof the anisotropic conductive film as measured at 25&#xb0; C., and Mis a elastic modulus in kgf/cmof the anisotropic conductive film as measured at 25&#xb0; C. after the film is left at 25&#xb0; C. for 170 hours.

Semiconductor device connected by anisotropic conductive film

An EVA sheet for a photovoltaic module comprising microparticles, the main component of which is an ethylene-vinyl acetate resin is provided. A method for manufacturing an EVA sheet for a photovoltaic module comprising the steps of: (a) preparing microparticles, the main component of which is an ethylene-vinyl acetate resin; (b) dispersing the microparticles; and (c) sintering the dispersed microparticles is provided.

Eva sheet comprising microparticles for solar cell and method for manufacturing the same

A semiconductor device connected by an anisotropic conductive film. The anisotropic conductive film includes a composition for an anisotropic conductive film including a first epoxy resin having an exothermic peak temperature of about 80&#xb0; C. to about 110&#xb0; C. and a second epoxy resin having an exothermic peak temperature of 120&#xb0; C. to 200&#xb0; C., as measured by differential scanning calorimetry (DSC). The first epoxy resin and the second epoxy resin are present in combined amount of about 30 wt % to about 50 wt % based on a total weight of the composition in terms of solid content. The second epoxy resin is present in an amount of about 60 to about 90 parts by weight based on 100 parts by weight of the first and second epoxy resins.

The present invention relates to an electronic device and a method of controlling the same. An electronic device according to an embodiment of the present invention converts the state of a page displayed on a touchscreen to a standby state through rear input and cancels the standby state upon release of the rear input, thereby providing a page corresponding to a desired time when the rear input is released.

Electronic device comprising a touch-screen display and a rear input unit, and method of controlling the same

The present invention relates to a composition comprising a material for inhibiting stem cell factor (SCF) or the receptor thereof for treating or preventing vascular permeability related diseases. Also, the present invention relates to a method for screening for an agent for treating vascular permeability related diseases, comprising the steps of: (a) treating a sample from a patient suspected of having a disease associated with vascular permeability with a candidate material; and (b) comparing the level of expression of the SCF or the receptor thereof with that of a control group. The present invention verifies SCF as a novel target for regulating vascular permeability. When the present invention is used, vascular permeability is decreased in diseases of the eye involving increased vascular permeability, thereby effectively treating or preventing vascular permeability related diseases. Also, vascular permeability can be effectively regulated using the composition. Further, the present invention can be provided as an effective means for screening an agent for treating vascular permeability related diseases by measuring the regulation of the expressions of SCF and c-Kit.

Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability

Disclosed is a sustained release lipid pre-concentrate, comprising: a) a sorbitan unsaturated fatty acid ester having a polar head with at least two or more &#x2014;OH (hydroxyl) groups; b) a phospholipid; and c) a liquid crystal hardener, free of an ionizable group, having a hydrophobic moiety of 15 to 40 carbon atoms with a triacyl group or a carbon ring structure. The lipid pre-concentrate exists as a liquid phase in the absence of aqueous fluid and forms into a liquid crystal in the presence of aqueous fluid. Also, a pharmaceutical composition further comprising a pharmacologically active ingredient plus the pre-concentrate is provided.

Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same

The present invention relates to a pharmaceutical composition for treating or preventing diseases caused by vascular permeability, containing imatinib, which has been conventionally used as an agent for treating chronic myeloid leukemia, or a pharmaceutically acceptable salt thereof as an active ingredient, and a method for treating disease caused by vascular permeability using the composition. The pharmaceutical composition for treating or preventing diseases caused by vascular permeability of the present invention contains imatinib, which has been conventionally used as an agent for treating chronic myeloid leukemia, as an active ingredient, so as to provide a novel use of imatinib and to be able to effectively treat or prevent diseases caused by vascular permeability, and thus may be widely applied to develop a novel agent for treating diseases caused by vascular permeability.

Composition for treating or preventing diseases caused by vascular permeability, containing imatinib or pharmaceutically acceptable salt thereof as active ingredient

Growing community of inventors

Seoul, South Korea

Ji Yeon Kim